TISSUE REGENERATION TECHNOLOGIES, LLC - TRT - Home

The FDA has approved the use of Paclitaxel in combination with Avastin specifically as this combination was found to prolong the progression of metastatic breast cancer in a phase III clinical trial. Nab-Paclitaxel (Abraxis BioScience, LLC… ................
................